Cure CMD L-CMD Research Grant
Funds accredited research institutions developing treatments and care improvements for congenital-onset laminopathies with grants up to $100,000.
Eligibility · Global — no geographic restrictions
Cure CMD administers this international research grant under its 2026 Request for Applications for congenital muscular dystrophy. It provides up to USD 100,000 for as much as two years of work on congenital-onset laminopathies, also called L-CMD. The funded work can cover the causes of the disease, new treatment targets, gene-based approaches, preclinical testing, disease models, biomarkers and to…
Research on L-CMD disease mechanisms, cardiac and muscle complications, therapeutic targets, preclinical treatments, disease models, biomarkers and trial-readiness tools.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up